You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0215 Subcutaneous Tocilizumab as Monotherapy or in Combination with A csDMARDs in Patients with Rheumatoid Arthritis – Interim Analysis of A Large Phase IV International Umbrella Study, “Tozura”

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0215 Subcutaneous Tocilizumab as Monotherapy or in Combination with A csDMARDs in Patients with Rheumatoid Arthritis – Interim Analysis of A Large Phase IV International Umbrella Study, “Tozura”

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016500
Aug 20161903
Sep 2016604
Oct 2016802
Nov 20161705
Dec 2016601
Jan 20171502
Feb 2017701
Mar 20171806
Apr 20171302
May 20171706
Jun 20172604
Jul 20175008
Aug 20175403
Sep 20172609
Oct 201744015
Nov 20172402
Dec 20171400
Jan 20181401
Feb 20181200
Mar 20182000
Apr 20181800
May 20183601
Jun 20181402
Jul 20182802
Aug 20182803
Sep 20181201
Oct 20181200
Nov 20181000
Dec 20181200
Jan 2019600
Feb 2019601
Mar 2019800
Apr 2019400
May 2019800
Jun 2019401
Jul 20191002
Aug 2019400
Oct 20191000
Nov 2019601
Dec 2019800
Feb 2020600
Apr 2020200
May 20201001
Jun 2020800
Jul 2020600
Aug 2020200
Sep 20202202
Oct 2020200
Nov 2020801
Dec 2020800
Jan 2021400
Mar 2021600
Apr 2021200
May 2021300
Aug 2021100
Oct 2021900
Nov 20211000
Dec 2021800
Jan 2022800
Feb 2022600
Mar 2022200
Apr 20221100
May 20221200
Jun 20229803
Jul 20221200
Aug 20222700
Sep 2022600
Oct 20221200
Nov 20221200
Dec 20222700
Jan 20232500
Feb 2023400
Mar 20231000
May 2023600
Jun 20232200
Jul 20234000
Aug 20234801
Sep 20231000
Oct 2023400
Nov 2023400
Dec 2023800
Jan 20242100
Feb 2024600
Mar 2024800
Total1225096